Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Treasury Shares: 2018-2025

Historic Treasury Shares for Aytu Biopharma (AYTU) over the last 8 years, with Sep 2025 value amounting to $31,294.

  • Aytu Biopharma's Treasury Shares rose 72.12% to $31,294 in Q3 2025 from the same period last year, while for Sep 2025 it was $31,294, marking a year-over-year increase of 72.12%. This contributed to the annual value of $32,912 for FY2025, which is 36.54% up from last year.
  • According to the latest figures from Q3 2025, Aytu Biopharma's Treasury Shares is $31,294, which was down 4.92% from $32,912 recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Treasury Shares registered a high of $2.2 million during Q4 2021, and its lowest value of $1,786 during Q1 2021.
  • Its 3-year average for Treasury Shares is $33,770, with a median of $34,528 in 2025.
  • Per our database at Business Quant, Aytu Biopharma's Treasury Shares plummeted by 99.95% in 2021 and then soared by 119,579.79% in 2022.
  • Aytu Biopharma's Treasury Shares (MRQ) stood at $2.2 million in 2021, then plummeted by 98.00% to $43,276 in 2022, then decreased by 12.36% to $37,929 in 2023, then dropped by 4.42% to $36,252 in 2024, then dropped by 13.68% to $31,294 in 2025.
  • Its Treasury Shares was $31,294 in Q3 2025, compared to $32,912 in Q2 2025 and $34,528 in Q1 2025.